Preclinical investigations

Knee x-ray
#Cancer research #Cancer treatment #Genetics / genomics #Oncology #Preclinical investigations #University of East Anglia

Bone cancer drug increases survival rates by 50%

Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer. The study shows how a breakthrough drug called CADD522 blocks a gene associated with driving the cancer’s spread in mice implanted with… Read More

#Cancer Research #Editor's Choice #News

Tooth loss
#Age-related diseases (ARDs) #Preclinical investigations #Regenerative Medicine

Regenerative drug completely restores bone in preclinical study

A new study has demonstrated the ability of an experimental regenerative medicine to restore bone in an animal.  Bone loss is a part of ageing that compromises quality of life and movement in many older people, but regenerative treatments to improve their health and well-being have been… Read More

#Editor's Choice

E coli bacteria
#Anti-inflammatory #Bacteria #Immune response #Immune system #Molecular Biology #mRNA #Preclinical investigations

Scientists use mRNA to reprogramme the immune system

University of Queensland researchers have identified a pathway in cells that could be used to reprogramme the body’s immune system to fight back against both chronic inflammatory and infectious diseases. Dr Kaustav Das Gupta and Professor Matt Sweet from UQ’s Institute for Molecular Bioscience discovered that a molecule… Read More

#News

Pancreatic cancer
#Antibodies #Cancer immunotherapy #Cancer research #Immunotherapy #Oncology #Pancreatic cancer #Preclinical investigations

Triple immunotherapy eliminates pancreatic tumours

A novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells, has significantly improved anti-tumour responses in preclinical models of pancreatic cancer.  In the study, published in Nature Cancer, researchers at The University of Texas MD Anderson Cancer Center… Read More

#Cancer Research #Editor's Choice #News

Woman doing clinical research
#Computational chemistry #Drug discovery #Drug repurposing #Idiopathic pulmonary fibrosis #Lung disease #Medicines repurposing #Preclinical investigations

Cancer drug shows promise in treating incurable lung disease 

Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF).   Saracatinib worked as well or better than two approved drugs at reducing tissue scarring in preclinical models of IPF according to the study published in the American Journal of… Read More

#News

#Automation / robotics #Cell and gene therapy #Drug Discovery 2022 #Drug screening #ELRIG #Preclinical investigations #Sustainability

The trends driving ELRIG Drug Discovery 2022

DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. Taking place at the ExCel in London from 4-5 October, ELRIG Drug Discovery 2022 is set to provide visitors with access to the latest trends, technologies and… Read More

#Exclusive Content

Medical research
#Mergers and acquisitions #Preclinical development #Preclinical investigations #R&D #Research services

BioIVT acquires research services company XenoTech

BioIVT has acquired XenoTech, a provider of products and services for preclinical testing that specialises in ADME, DMPK and DDI testing of potential drug candidates.  Through the acquisition, BioIVT aims to expand the portfolio of research models and services that are available to its clients to support… Read More

#News

#Drug efficacy #Drug safety #Drug toxicity #Preclinical investigations

How to enhance the predictability of preclinical development: webinar

Effective preclinical assessment of drug safety and efficacy is essential to help reduce the risk of drug-induced toxicity and late-stage drug attrition. Current preclinical tests for safety depend on in vivo testing in higher-order species to achieve translational accuracy; however, animal models are expensive and do not adequately recapitulate human… Read More

#Editor's Choice #News